Cart (0 Items)
Your cart is currently empty.
View ProductsStable Isotope Labelled Cetuximab Biosimilar – Anti-hEGFR mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Isotope Labelled Cetuximab Biosimilar - Anti-hEGFR mAb - Research Grade |
|---|---|
| Source | EMBL-EBI PDB-5iv2 |
| Species | Mouse/Human |
| Expression system | Mammalian cells |
| Molecular weight | LC: 23kDa HC: 23kDa |
| Purity | >95% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Applications | MS |
| Aliases /Synonyms | Cetuximab |
| Reference | PX-TA1019-SIL |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | FabG1Kappa |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
Description of Stable Isotope Labelled Cetuximab Biosimilar - Anti-hEGFR mAb - Research Grade
General information about Cetuximab
Cetuximab is a chimeric (mouse/human) monoclonal antibody. It inhibits epidermal growth factor receptor (EGFR) and is used to treat metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. This product is for research use only.
Reviews
Il n’y a pas encore d’avis.